- Home
- OOMA vs NVCT Comparison
OOMA vs NVCT Comparison
Compare OOMA & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OOMA | NVCT |
|---|---|---|
| Founded | 2003 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 517.6M | 617.7M |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | OOMA | NVCT |
|---|---|---|
| Price | $20.56 | $25.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $18.77 | $10.00 |
| AVG Volume (30 Days) | ★ 357.3K | 201.0K |
| Earning Date | 05-27-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 188.46 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $114,490,000.00 | N/A |
| Revenue This Year | $20.35 | N/A |
| Revenue Next Year | $4.17 | N/A |
| P/E Ratio | $228.78 | ★ N/A |
| Revenue Growth | ★ 9.53 | N/A |
| 52 Week Low | $9.79 | $5.55 |
| 52 Week High | $22.72 | $29.28 |
Technical Indicators
Market Signals| Indicator | OOMA | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 45.83 | 72.87 |
| Support Level | $19.49 | $17.98 |
| Resistance Level | $21.57 | $29.28 |
| Average True Range (ATR) | 0.92 | 1.31 |
| MACD | -0.13 | 0.57 |
| Stochastic Oscillator | 14.41 | 97.65 |
Price Performance
Historical ComparisonAbout OOMA Ooma Inc.
Ooma Inc is a communications services company. It is a smart software-as-a-service (SaaS) and unified communications platform that delivers voice and collaboration features, including messaging, intelligent virtual attendants, and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. It generates revenues from the sale of subscriptions and other services.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.